Human Chorionic Gonadotropin (HCG) Market
The placenta secretes human chorionic gonadotropin hormone (HCG), a hormone, after implantation of a fertilized zygote in the uterus. HCG plays a major role in stimulating the egg release from the ovary and promotes normal development of the egg. In infertility treatment, the HCG induces ovulation in the women and increase the sperm count in males.
Get PDF Brochure Of This Report With Detailed Analysis @ https://www.coherentmarketinsights.com/insight/request-pdf/1011
Major players operating in the global human chorionic gonadotropin market are focused on R&D to expand their product portfolio. For instance, in September 2021, Pfizer Inc. and OPKO Health Inc. announced that the U.S. Food and Drug Administration extended the review period for the Biologics License Application for somatrogon, a long-acting human growth hormone (hGH) molecule, is a once-weekly injectable, created using recombinant technology for the treatment of pediatric and adult growth hormone deficiency.
Global Chorionic Gonadotropin (HCG) Market: Drivers
High incidence of infertility is expected to propel growth of the global human chorionic gonadotropin market over the forecast period. For instance, according to the National Survey of Family Growth data published in September 2018, 15.5% of all women who intend to become pregnant are infertile and 6.7% of married women aged 15 to 44 years are infertile, in the U.S.
Moreover, high incidence of endometriosis, hormonal imbalance, and polycystic ovary syndrome is also expected to aid in growth of the market. For instance, according to the study ‘The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis’, published in September 2019, the prevalence of polycystic ovarian syndrome in adolescents based on the Rotterdam criteria was 11.04%, based on the National Institute of Health criteria, it was 3.39%, and based on Androgen Excess and Polycystic Ovary Syndrome Society, it was 8.03%.
North America is expected to witness significant growth in the global human chorionic gonadotropin market, owing to the rising number of infertility cases in the region. For instance, according to Mayo Clinic, around 25% of women fertility problems in the U.S. are a result of ovulation issues that are mostly caused due to dysfunction of human chorionic gonadotropin (HCG) hormone.
Global Chorionic Gonadotropin (HCG) Market: Restraints
Availability of alternatives to treat infertility is expected to limit growth of the global human chorionic gonadotropin market.
Buy This Research Study Report For Quick Access@ https://www.coherentmarketinsights.com/insight/buy-now/1011
Global Chorionic Gonadotropin (HCG) Market: Competitive Analysis
Major players operating in the global human chorionic gonadotropin market include, Bristol Myers Squibb Company, EMD Sereno, Inc., Fresenius Kabi, Ferring BV, Kamia Biomedical Company, and Merck & Co., Inc.and Kamia Biomedical Company. Acris Antibodies developed a human chorionic gonadotropin hormone by recombinant DNA technology that helps to prevent the disintegration of the corpus luteum of the ovary thereby, maintaining levels of progesterone production for healthy pregnancy in females.
Global Chorionic Gonadotropin (HCG) Market: Taxonomy
- Natural Source Extraction
- Recombinant DNA Technology
- By Therapeutic Area
- Female infertility treatment
- Oligospermic Treatment
- Cryptorchidism Treatment
By End User
- Fertility Centers
- Research Institutes
- North America
- Latin America
- Asia Pacific
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027